Identifying and providing clarity on the GCP quality and risk concerns associated with DCT modalities.
Max Luccock
Advertisement
Max Luccock works within ZS’s digital and DCT vertical in clinical development and medical affairs practices, and is an associate consultant at the Evanston, Illinois, office.
Articles by Max Luccock
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Design Flaws Trial Simulations Surface That Traditional Planning Misses
2
How AI Is Changing Endpoint Selection Before a Trial Even Starts
3
Quantifying the Financial Value of RBQM: Q&A with Sylviane de Viron, CluePoints, and Abigail Dirks, Tufts CSDD
4
ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval
5